Category
Financial Analytics
Forensic financial analysis for dental practices and DSOs: EBITDA defence, M&A due diligence, practice valuations, Quality of Earnings, and exit preparation.
53 articles
What Comes Off Your Number: The 14 Ways a Buyer Reprices a Dental Practice's EBITDA
In a dental practice sale, the add-backs list runs in reverse. The 14 adjustments a buyer's diligence team makes to EBITDA, grouped by what each comes off: the price, the terms, or the cash at close, with what each one costs at 7x.
The SBA Just Made Phantom EBITDA a Loan Condition
From October 1, a $3 million practice purchase financed through an SBA 7(a) loan needs an independent Quality of Earnings the seller can't supply. Here is what it will find, and what it won't.
The Three Faces of Phantom EBITDA
Phantom EBITDA has three faces: accounting, operational, clinical. Each is found by a different reader on the buyer's side and prices differently. One $10M practice, all three.
The Point Guard: The Key-Person Risk Financial Diligence Can't See
The owner produced 4.8% of the practice — and originated 24.6% of everything it diagnosed. Diagnostic dependency is the key-person risk no QoE report measures.
The Second Bite: How Rollover Equity Works and Who Gets Paid First
Rollover equity is a security — minority, illiquid, leveraged, with an exit you don't control. The five questions that decide whether it's a second bite or a second haircut.
The Clinical Ledger: The Half of Practice Value Your P&L Cannot Show
Every dental practice has two ledgers. The financial ledger records results; the Clinical Ledger reconstructs the system that produced them — and whether it transfers.
The Moving Target: How Dental Practice Earnouts Are Measured and Controlled
An earnout is not a number — it is a measurement system administered by the buyer for 3-5 years. The five clauses that decide whether yours pays $2.1M or $0.
The Blind Claim: The Three Hidden Failure Points Where Your Enterprise Value Is Actually Decided
Buy-side diligence rebuilds your EBITDA from your PMS data. The three failure points where enterprise value is decided — and how sellers defend each one.
The 3% Myth: What the Insurance Utilization Stat Is Actually Hiding
Why the 3% insurance utilization stat is a denominator problem — and what a 94% case acceptance rate on $320 average presentations is actually hiding.
The Graded Exam: Why Your Earnout Is Scored by the Person Who Owes the Money
An earnout is 10-30% of a dental practice sale, paid only if targets are hit — targets the buyer models, under operations the buyer controls, measured on the buyer's books. The mechanics, the tax trap, and the five clauses that un-tilt the table.
The Paper Millionaire: What Your Rollover Equity Is Actually Worth
Rollover equity is 20-40% of a dental practice sale taken as stock in the buyer's platform. The buyer audits you for 90 days; most sellers audit the buyer over a dinner. The five-question diligence every seller owes their second bite.
Toxic Top-Line: The Revenue That Counts Until Someone Checks
A $12M practice with clean books carried $227K of production a buyer's analyst refused to price. Real revenue, collected and booked — but not defensible. One code ratio exposed $650K of enterprise value, and the fix was paperwork.
The CPA Trap: Why Financial Historians Cannot Fight Data Wars
Your CPA is a trusted advisor and a skilled financial historian — and structurally unequipped to defend a practice sale. Why QoE teams bypass the General Ledger, attack the Clinical Ledger, and what a seller's defense actually requires.
The Handshake Valuation: Why Selling to Your Associate Is the Most Mispriced Deal in Dentistry
Selling a dental practice to an associate skips the auction — and usually the forensics. How internal transitions get priced by relationship, why the seller becomes the bank, and what a defensible internal deal requires.
The Net Number: Why Your Multiple Isn't the Money You Keep
Two dentists sell for the same $5M headline, but one keeps $700K more. How deal structure — asset vs. stock sale, purchase-price allocation, and entity type — decides your after-tax dental practice sale proceeds.
The Broker's Prospectus: A Marketing Brochure, Not a Forensic Baseline
A broker's prospectus is a marketing brochure, not due diligence. Why buying a dental practice on reported collections and a few KPIs is a faith-based multiple — and what a forensic clinical baseline reveals that the prospectus hides.
The Boutique Fallacy: Why Size Sets Your Dental Practice Value
Two dental practices, same profit, can sell millions apart. Why size — not margin — decides whether you get an SDE multiple or an institutional DSO/EBITDA exit.
The Consultant's Mirage: Why Standard Advice Fails a Dental QoE Audit
The standard dental consultant advice — boost production, cut overhead — is exactly what gets your EBITDA slaughtered in a buyer's Quality of Earnings audit.
Personal Goodwill: Why a Dental Buyer Can Withhold Your Cash
Goodwill is 75% to 85% of a dental practice's price, and buyers only pay full for goodwill that transfers. How personal goodwill and a 5% to 25% key-person discount cost you at close.
The LOI Is Not the Deal: The Chronological Anatomy of a 90-Day Enterprise Value Extraction
85% of dental practice sellers lose enterprise value after the buyer's Quality of Earnings audit. Here is the exact chronological anatomy of what happens inside the 90-day exclusivity window — and how $4.2M becomes $3.15M.
The Overhead Lie: Why Your Practice's 60% Is Hiding a Valuation Problem
Your 60% overhead looks fine on a P&L. An institutional buyer sees something different entirely. Here's what the benchmarks actually mean at exit — and what they hide.
The Defense Gap: How Private Equity Monetizes Asymmetric Diligence in Dental M&A
Buy-side diligence teams spend $1.2-3M per transaction while sellers spend almost nothing. SRS Acquiom data shows 85% of deals face post-LOI adjustments. Here's why the clinical data layer is where dental-specific value extraction happens.
Successor Liability: The Algorithmic Cost of the Independent Contractor
The 1099 associate structure is the most common staffing decision in dentistry — and the most calculable forensic liability at exit. Here is exactly how buyers price it, from successor liability escrow to the compensation cascade.
Nonprofit for Taxes, For-Profit at the Top: The Hidden Fee Schedule Cliff in Your Practice Valuation
Delta Dental Premier status is tied to the provider, not the practice. When the selling dentist leaves, that fee schedule leaves with them — and a 30% revenue reduction on day one is a $420,000 swing in enterprise value at a 7x multiple.
What Is My Dental Practice Worth? Why the Answer Depends Entirely on Who's Buying
The value of your dental practice depends entirely on who is buying. Here is how individual buyers and institutional buyers calculate it — and why those are two different numbers.
Dental Practice Exit Strategy: The 5-Year Forensic Blueprint for an Institutionally Auditable Sale
A year-by-year dental practice exit strategy for building a practice that institutional buyers pay premium multiples for — the forensic blueprint starting 5 years before you sell.
The $250,000 Audit: How Retroactive Payer Downgrades Destroy Enterprise Value
A $25,000 insurance chargeback becomes a $250,000 enterprise value reduction at a 10x multiple. Here's how retroactive payer audits and QoE extrapolation compound to destroy dental practice valuations.
The KPIs That Kill Your Multiple: Which Dental Practice Metrics Institutional Buyers Actually Score
Not all dental KPIs matter at exit. Here are the metrics PE-backed buyers weight most, the thresholds that move multiples, and the vanity metrics they ignore entirely.
How DSOs Actually Evaluate Your Dental Practice: The 11 Underwriting Criteria They Score But Never Publish
Former NADG regional director reveals the 11 criteria DSO underwriting teams actually score — and the specific thresholds that separate premium multiples from discount ones.
Governance Debt: The Compounding Liability Silently Eroding Your Practice's Enterprise Value
Governance debt — compliance gaps, undocumented SOPs, key-person risk — compounds silently and surfaces during due diligence. Here's how to quantify and eliminate it before a buyer's algorithm does.
The Dental Practice Data Room: What to Build, How to Structure It, and Why Starting 5 Years Early Changes Your Multiple
Most sellers assemble data rooms in 60 days. Here's the forensic-grade folder structure PE buyers actually expect — and why building it early changes your multiple.
The Algorithmic Denial Machine: How Payer AI Is Weaponizing Your Radiographs
Insurance payers are deploying pixel-level AI to deny claims at scale. The same weaponization PE firms use during QoE is coming to every claim you submit.
The Data Room Nobody Builds: What Buyers See That Sellers Never Prepare
A QoE team spends 30 days dismantling the story you spent 30 years building. Sellers who pre-audit their data room dictate the terms of their exit.
The Silent Margin Collapse: Clinical Judgment as Enterprise Value Destruction
A single D4910-to-D1110 downgrade costs $70. Repeated daily across 3 locations, it erases $504,000 in enterprise value at a 6x multiple.
The Practice That Should Have Sold: What Dentists Get Wrong About Selling
A practice with strong collections sat on the market for 30 months because the operational narrative went cold. The three-year mistake explained.
The Due Diligence Ambush: How PE Weaponizes Your Data to Hijack Your Exit
Private Equity QoE teams extract raw PMS data to systematically dismantle your EBITDA. A $3M group lost $13.8M in enterprise value to unsanitized data.
EBITDA Laundering: The Clinical Blind Spot in Dental M&A
The EBITDA Laundering blind spot in dental M&A: how compliant-looking revenue masks clinical fraud that survives standard due diligence.
The Dashboard Charade: Why Your Case Acceptance Rate is a Dangerous Hallucination
A 48% dollar acceptance rate is often 75% once the Multi-Option Flaw is cleaned out. Why dashboards fail at case acceptance and net production, and the monthly truth-check protocol.
The "Cash Flow" Mirage: Why Profitable Practices Go Broke in Year 1
The prospectus shows $280,000 in free cash flow. Year one brings market-rate wages, 10–15% attrition, debt service, and deferred equipment — a ~$330,000 swing. The Double Crush, itemized.
The Dashboard Trap: Why 'More Data' is Making You Poor
A dashboard is a speedometer: it shows what happened, not why yield fell. The three-level Data Pyramid, the Leaky Bucket, and why new patients up 15% can hide 20% attrition.
The EBITDA Illusion: Why DSOs Buy You at 5x and Trade at 14x (And How to Keep the Difference)
Why dental DSOs trade at 14x while acquirers pay 5x — understand the Multiple Arbitrage mechanism that transfers wealth from practices to PE.
The Hygiene Asset: Why Your Recall System Is Your Practice's 401(k)
Hygiene is the only revenue in a dental practice that runs without the owner's hands. Hygiene share of production, the 30% perio benchmark, 90% reappointment, and the 3-minute exam.
Income Rich, Asset Poor: The High-Production Valuation Trap
An $800,000 owner income is a replacement cost, not profit: the buyer deducts 30–35% of your production to pay your successor. Owner-dependent at 5–8x versus platform-ready at 9–11x.
The Hidden Margin Killer: Why Your Busy Dental Practice Isn't as Profitable as You Think
65.8% of dentists raised fees 6.7% in 2025 while 35% report not being busy enough. Revenue is up because prices are, not patients. The fiscal squeeze, the 40.7%-to-25.7% execution gap, and the fix.
The Million-Dollar Mistake: Why Waiting Until You're Ready to Sell Could Cost You Your Legacy
Dentists who sell when they feel ready sell two to five years too late. $200,000 of added EBITDA at 6–7x is $1.2–1.4M of price left on the table, plus a smaller buyer pool.
Beyond Volume: The New Metrics of Practice Value in a Consolidating Market
Thirty new patients a month looks like growth. Raw new-patient counts hide value erosion as high-value, loyal patients are replaced by transactional ones. Measure value, not volume.
The Revenue Cycle Paradox: Why Your Busiest Months Can Have the Worst Cash Flow
Record net production of $145,000, collections of $127,000. Where the gap goes, the daily claim-scrubbing protocol, five weekly RCM metrics with targets, and a 90-day recovery plan.
Busy days, flat profit: why "good reports" miss performance—and what to measure instead
Production up 3%, collections 96%, 2,500 active patients — and $990,000 a year leaking through five gaps the PMS cannot see. KPIs versus Root Performance Indicators, with the math.
The Data-Driven Practice Advantage: Predictable Revenue, Minimized Risk, and EBITDA That Survives the Buyer's QoE
The data-driven practice advantage is not dashboards or software — it is predictable revenue, quantified risk, and an EBITDA figure that survives the buyer's Quality of Earnings audit without adjustment.
From Claim Chaos to Cash Flow: Data-Driven Strategies to Master Dental Insurance Collections
One practice had $1 million in insurance claims over 90 days old. The five coverage rules that stall claims, the weekly A/R review system, and how to keep patients out of surprise bills.
The Golden Handcuffs: Are You Subsidizing Insurance Companies Instead of Investing in Your Own Practice?
The $1,500 dental insurance maximum hasn't moved in 50 years. One owner wrote off $300,000 a year to stay in-network. The PPO subsidy math and the in-house membership plan alternative.
Unlocking Hidden Profits: How Dentists Can Reclaim Millions with Data-Driven Strategies
The average dental practice holds more than $700,000 in untapped annually recurring opportunity. Why raising fees, dropping plans, and extending hours are the wrong fixes, and the vital-few metrics that find it.
Analyzing Your Dental Practice's P&L: Setting the Course for 25% EBITDA
How to categorize a dental practice P&L, the expense percentages behind a 25% EBITDA margin, and the income goal math — including why owner compensation must be reset to market rate first.